Agios Pharmaceuticals: Liver Toxicity Issues May Threaten Thalassemia Approval (Rating Downgrade)
Despite promising Phase 3 results, safety concerns, namely liver injury, have impacted Agios stock and could affect Pyrukund's approval and market adoption. Read the full report here.
Hosted on MSN23h
Doncaster hospitals support Love Your Liver Month with free community and employee liver health checks
It’s fantastic to see so many people engaging with the Love Your Liver Roadshow and taking proactive steps to look after the ...